Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod

2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod

US Patent 11318130 · Granted May 3, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Acute delivery of a drug or fluid to an ocular surface2025
Lower dosage strength imiquimod formulations and short dosing regimens for treat2023
Methods of treating dermatological disorders and inducing interferon biosynthesi2021
Lower dosage strength imiquimod formulations and short dosing regimens for treat2021
Aqueous-based metronidazole gel formulations2020
Aqueous-based metronidazole gel formulations2020
Aqueous-based metronidazole gel formulations2019
Aqueous-based metronidazole gel formulations2019
2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical comp2019
2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical comp2019
2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical comp2019
2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical comp2019